Bibliography
- Gurtner GC , WernerS, BarrandonY, LongakerMT: Wound repair and regeneration.Nature453(7193) , 314–321 (2008).
- Kehlet H , HolteK: Effect of postoperative analgesia on surgical outcome.Br. J. Anaesth.87(1) , 62–72 (2001).
- Roy S , KhannaS, RinkC, BiswasS, SenCK: Characterization of the acute temporal changes in excisional murine cutaneous wound inflammation by screening of the wound-edge transcriptome.Physiol. Genomics34(2) , 162–184 (2008).
- Martin P , LeibovichSJ: Inflammatory cells during wound repair: the good, the bad and the ugly.Trends Cell Biol.15(11) , 599–607 (2005).
- Egozi EI , FerreiraAM, BurnsAL, GamelliRL, DipietroLA: Mast cells modulate the inflammatory but not the proliferative response in healing wounds.Wound Repair Regen.11(1) , 46–54 (2003).
- Martin P , D‘souzaD, MartinJ et al.: Wound healing in the PU.1 null mouse – tissue repair is not dependent on inflammatory cells.Curr. Biol.13(13) , 1122–1128 (2003).
- Low QE , DrugeaIA, DuffnerLA et al.: Wound healing in MIP-1α-/- and MCP-1-/- mice.Am. J. Pathol.159(2) , 457–463 (2001).
- Devalaraja RM , NanneyLB, DuJ et al.: Delayed wound healing in CXCR2 knockout mice.J. Invest. Dermatol.115(2) , 234–244 (2000).
- Dipietro LA , ReintjesMG, LowQE, LeviB, GamelliRL: Modulation of macrophage recruitment into wounds by monocyte chemoattractant protein-1.Wound Repair Regen.9(1) , 28–33 (2001).
- Hu Y , LiangD, LiX et al.: The role of interleukin-1 in wound biology. Part I: murine in silico and in vitro experimental analysis.Anesth. Analg.111(6) , 1525–1533 (2010).
- Zheng M , ShaferSS, LiaoG, Liu H-H, Peltz G: Computational genetic mapping in mice: ‘The Ship has Sailed‘. Sci. Transl. Med.1(3) , 3ps4 (2009).
- Hu Y , LiangD, LiX et al.: The role of interleukin-1 in wound biology. Part II: in vivo and human translational studies.Anesth. Analg.111(6) , 1534–1542 (2010).
- Mertens M , SinghJA: Anakinra for rheumatoid arthritis: a systematic review.J. Rheumatol.36(6) , 1118–1125 (2009).
- Fleischmann RM , TesserJ, SchiffMH et al.: Safety of extended treatment with anakinra in patients with rheumatoid arthritis.Ann. Rheum. Dis.65(8) , 1006–1012 (2006).
- Yang BB , BaughmanS, SullivanJT: Pharmacokinetics of anakinra in subjects with different levels of renal function.Clin. Pharmacol. Ther.74(1) , 85–94 (2003).
- Thomay AA , DaleyJM, SaboE et al.: Disruption of interleukin-1 signaling improves the quality of wound healing.Am. J. Pathol.174(6) , 2129–2136 (2009).
- Ishida Y , KondoT, KimuraA, MatsushimaK, MukaidaN: Absence of IL-1 receptor antagonist impaired wound healing along with aberrant NF-κB activation and a reciprocal suppression of TGF-β signal pathway.J. Immunol.176(9) , 5598–5606 (2006).
- Zhang X , KohliM, ZhouQ, GravesDT, AmarS: Short- and long-term effects of IL-1 and TNF antagonists on periodontal wound healing.J. Immunol.173(5) , 3514–3523 (2004).
- Wilusz RE , WeinbergJB, GuilakF, McnultyAL: Inhibition of integrative repair of the meniscus following acute exposure to interleukin-1 in vitro.J. Orthop. Res.26(4) , 504–512 (2008).
- Genovese MC , CohenS, MorelandL et al.: Combination therapy with etanercept and anakinra in the treatment of patients with rheumatoid arthritis who have been treated unsuccessfully with methotrexate.Arthritis Rheum.50(5) , 1412–1419 (2004).
- Martinelli I , BucciarelliP, MannucciPM: Thrombotic risk factors: basic pathophysiology.Crit. Care Med.38(2 Suppl.) , S3–S9 (2010).
- Mackman N : Role of tissue factor in hemostasis, thrombosis, and vascular development.Arterioscler. Thromb. Vasc. Biol.24(6) , 1015–1022 (2004).
- Li WW , GuoTZ, LiangD et al.: The NALP1 inflammasome controls cytokine production and nociception in a rat fracture model of complex regional pain syndrome.Pain147(1–3) , 277–286 (2009).
- Newman S , StygallJ, HiraniS, ShaefiS, MazeM: Postoperative cognitive dysfunction after noncardiac surgery: a systematic review.Anesthesiology106(3) , 572–590 (2007).
- Hailer NP , VogtC, KorfHW, DehghaniF: Interleukin-1β exacerbates and interleukin-1 receptor antagonist attenuates neuronal injury and microglial activation after excitotoxic damage in organotypic hippocampal slice cultures.Eur. J. Neurosci.21(9) , 2347–2360 (2005).
- Sanderson KL , RaghupathiR, SaatmanKE, MartinD, MillerG, McintoshTK: Interleukin-1 receptor antagonist attenuates regional neuronal cell death and cognitive dysfunction after experimental brain injury.J. Cereb. Blood Flow Metab.19(10) , 1118–1125 (1999).
- Terrando N , Rei Fidalgo A, Vizcaychipi MP et al.: The impact of IL-1 modulation on the development of lipopolysaccharide-induced cognitive dysfunction. Crit. Care14(3) , R88 (2010).
- Niethammer P , GrabherC, LookAT, MitchisonTJ: A tissue-scale gradient of hydrogen peroxide mediates rapid wound detection in zebrafish.Nature459(7249) , 996–999 (2009).
- Zhang Q , ItagakiK, HauserCJ: Mitochondrial DNA is released by shock and activates neutrophils via p38 MAP-kinase.Shock34(1) , 55–59 (2010).
- Wannamaker W , DaviesR, NamchukM et al.: (S)-1-((S)-2-{[1-(4-amino-3-chloro-phenyl)-methanoyl]-amino}-3,3-dimethyl- butanoyl)-pyrrolidine-2-carboxylic acid ((2R,3S)-2-ethoxy-5-oxo-tetrahydro-furan-3-yl)-amide (VX-765), an orally available selective interleukin (IL)-converting enzyme/caspase-1 inhibitor, exhibits potent anti-inflammatory activities by inhibiting the release of IL-1β and IL-18.J. Pharmacol. Exp. Ther.321(2) , 509–516 (2007).